| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
3.23 0.03 (0.01%) |
11-15 16:00 |
|
Open: |
3.28 |
Pre close: |
3.2 |
Target:
|
4.34
|
|
High: |
3.28 |
Low: |
3.18 |
Resistance:
|
3.71
4.05
|
|
Volume: |
23,288 |
Market Cap: |
51M |
Support:
|
3.17
2.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.27
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
3.41 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
4.26 |
Stochastic Oscillator |
%K(14,3):
|
11.99 |
|
MA(250): |
6.81 |
%D(3): |
13.77 |
|
Average Volume(K) |
3-Month: |
4897
|
52-Week |
High:
|
11.90 |
|
10-Days: |
7386 |
Low: |
3.17 |
|
RSI |
RSI(14):
|
37.92  |
Change(%): |
-70.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.523 |
Return on Equity (ttm) |
-172.4 |
Shares Out. (M) |
15.31 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-72.2 |
Shares Float (M) |
14.58 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.43 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.33 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.003 |
Shares Short (K) |
179 |
|
Book Value (p.s.) |
1.120 |
EBITDA (p.s.) |
-2.079 |
P/E |
-1.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.18 |
P/S |
0.00 |
|
Operating Margin |
-67514.00 |
Levered Free Cash Flow
(M) |
-14.79 |
P/CF |
-1.75 |
|
|
|
|
|
|
